Elucidating the Inability of Functionalized Nanoparticles to Cross the Blood-Brain Barrier and Target Specific Cells in Vivo.
Naidu PSR, Gavriel N, Gray CGG, Bartlett CA, Toomey LM, Kretzmann JA, Patalwala D, McGonigle T, Denham E, Hee C, Ho D, Taylor NL, Norret M, Smith NM, Dunlop SA, Iyer KS, Fitzgerald M.
Naidu PSR, et al. Among authors: toomey lm.
ACS Appl Mater Interfaces. 2019 Jun 26;11(25):22085-22095. doi: 10.1021/acsami.9b01356. Epub 2019 Jun 12.
ACS Appl Mater Interfaces. 2019.
PMID: 31150197